It was revealed that VIRMA knockdown could suppress the expression of stem factors Notch1, Oct4, Nanog and CD44 in osteosarcoma cells, which suggested that VIRMA promoted osteosarcoma progression by activating Notch signaling pathway [50]. This evidence concerns the gene NANOG and osteosarcoma.